Losing an earbud can make your expensive purchase useless, which is why many tech brands offer replacements for individual ...
Zacks Investment Research on MSN
DexCom (DXCM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
DexCom (DXCM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the ...
We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ ...
Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...
Walmart will become the first U.S. retailer to sell Abbott Laboratories' over-the-counter continuous glucose monitor Lingo in ...
The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.
San Diego-based Dexcom Inc., is the target of a class action lawsuit in U.S. district court over the company’s G7 continuous glucose monitors, an action which follows a U.S. FDA warning letter by a ...
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by ...
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...
Keegan Bradley wants change. Luke Donald says rules are rules. As the Ryder Cup ended Sunday at Bethpage Black, a Ryder Cup debate may have started. Whose thought wins out on the ‘envelope rule’ ...
10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results